Quality White Papers & Case Studies

51. Best Practices For Protein Analysis With An Analyzer System 6/18/2026

    Strong protein analysis relies on optimized preparation, buffer consistency, and precise method settings. Gain insight into how small changes in temperature, storage, or injection can impact accuracy.

52. Comparing Two CE-SDS Systems Using NISTmAb 6/18/2026

    Fluorescence and UV detection deliver highly comparable results in protein capillary electrophoresis. See how both approaches perform across systems and what it means for protein analysis.

53. Accurate mAb Sizing Using The NIST mAb As A Ladder 6/18/2026

    Improve your mAb sizing accuracy by integrating a well-characterized reference standard into your analysis workflows, which reduces variability and delivers more precise measurements.

54. Where Speed Meets Complexity In Bioprocess Development 6/18/2026

    Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.

55. Direct Amplification Of Cell Culture Samples 6/15/2026

    Skip extraction and move straight to amplification with a streamlined qPCR workflow. Achieve comparable performance across multiple targets while reducing costs and saving time.

56. qPCR Amplification Of Human Gastrointestinal Samples 6/15/2026

    Residual inhibitors in GI-derived DNA can hinder qPCR performance. An optimized approach improves inhibitor tolerance and enables earlier target detection, delivering more reliable amplification.

57. Unlocking The Full Potential Of Antibody-Drug Conjugates (ADCs) 6/15/2026

    ADCs are evolving rapidly. Gain insight into how success now hinges on managing complexity, delivery, and scalability to turn promising designs into viable therapeutic products.

58. ADC Manufacturing: Practices, Challenges, And The Road Ahead 6/15/2026

    ADCs are advancing quickly, but manufacturing complexity is rising just as fast. Key challenges in scale-up, regulation, and costs are reshaping how the next generation of therapies will be delivered.

59. Scalable rAAV9 Production Using Advanced Cell Lines And Bioreactors 6/15/2026

    Progress in gene therapy manufacturing is being driven by improved cell line performance and scalable bioprocessing. See how high-density growth helps streamline development to larger-scale production.

60. Leveraging Integrated Media Services For Speed And Efficiency 6/12/2026

    Uncertainty in media stability can limit efficiency and scalability in biologics manufacturing. See how a data-driven approach enables more predictable planning and reduces operational strain.